870. Olorofim for the treatment of invasive mould infections in patients with limited or no treatment options: Comparison of interim results from a Phase 2B open-label study with outcomes in historical control populations (NCT03583164, FORMULA-OLS, Study 32)

BACKGROUND: Olorofim is a novel antifungal agent active against Aspergillus spp (including azole-resistant strains), rare, resistant moulds (e.g., Lomentospora prolificans) and dimorphic moulds. Serial images of Lomentospora prolificans infection following breast enhancement surgery: progression of...

Descripción completa

Detalles Bibliográficos
Autores principales: Maertens, Johan A, Verweij, Paul E, Lanuza, Evan F, Harvey, Emma L, Dane, Aaron, Zinzi, Daniela, Rex, John H, Chen, Sharon C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752288/
http://dx.doi.org/10.1093/ofid/ofac492.063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752288/
http://dx.doi.org/10.1093/ofid/ofac492.063

Ejemplares similares